Key takeaways
- Semiconductor demand keeps growing: The global push toward AI infrastructure, cloud computing, and advanced electronics is creating massive demand for the companies that design and manufacture the hardware powering these trends, and Canada has real exposure to this theme.
- Celestica is a legitimate player: Celestica has transformed itself from a traditional contract manufacturer into a company with serious exposure to high-growth end markets like hyperscaler data centers, and its financial results have reflected that shift in a big way over the past couple of years.
- Valuation and concentration risk matter: When a stock runs as hard as Celestica has, you need to pay close attention to how much of the growth is already priced in and how reliant the business is on a handful of major customers, because losing even one contract can change the story fast.
Canada’s semiconductor exposure is thin. Really thin. The TSX doesn’t give you a deep bench of pure-play chip companies the way the NASDAQ does, and that’s left a lot of Canadian investors either ignoring the space entirely or buying semiconductor ETFs to get their fix. Neither approach is wrong, but there’s a name on the TSX that has quietly become one of the most impressive growth stories in the entire Canadian tech universe.
Celestica has been a monster. The stock’s trajectory over the past two years would make most mega-cap tech investors jealous, and the business behind it has genuinely transformed. This isn’t the same contract electronics manufacturer it was a decade ago. The company has repositioned itself as a critical supplier to hyperscale data centers, and the AI infrastructure buildout has poured fuel on that shift. Revenue growth, margin expansion, and a backlog that keeps getting fatter. It checks a lot of boxes.
My concern? Valuation. When a stock runs this hard, the market starts pricing in perfection, and perfection is a dangerous assumption for any company, no matter how strong the tailwinds are. The semiconductor supply chain is cyclical by nature, and the current AI spending boom won’t last at this pace forever. That doesn’t mean you should avoid the name. It means you need to understand what you’re paying for.
I also think it’s worth framing Celestica against the broader US tech giants that dominate most growth portfolios. Canadian investors tend to overlook homegrown companies that are competing on a global stage, and Celestica is absolutely doing that right now. The question is whether the current price already reflects the best-case scenario, or if there’s still room for the business to surprise to the upside.
I dug into the fundamentals, growth drivers, and risks to figure out where things stand today.
In This Article
- Celestica Inc. (CLS.TO)
Celestica Inc. (TSX: CLS)
Celestica Inc. is a Canadian-based multinational electronics manufacturing services provider that delivers design, engineering, and manufacturing solutions to various high-technology industries...
Competitive Edge
- Celestica is one of only a handful of EMS providers qualified to manufacture 800G and next-gen optical networking switches for hyperscalers. This isn't generic PCB assembly; it requires cleanroom-grade precision and co-engineering relationships that take years to replicate.
- Customer stickiness in AI/ML hardware is high because qualification cycles for networking equipment (particularly for Meta, Google, and Microsoft data centers) run 12-18 months. Switching EMS providers mid-program risks production delays that hyperscalers cannot tolerate.
- The IBM heritage gives Celestica deep vertical integration in complex PCBAs and system-level assembly that pure-play competitors like Flex or Jabil struggle to match in high-layer-count networking applications. This is a genuine capability moat, not a branding exercise.
- Geographic manufacturing diversification across Thailand, Malaysia, Romania, and Canada provides tariff optionality that single-country competitors lack. As US-China trade tensions reshape supply chains, Celestica's footprint is a structural advantage for Western OEMs.
By the Numbers
- ROIC of 33.4% on a debt-to-equity of just 0.34 means returns are driven by operational excellence, not financial engineering. Net debt/EBITDA of 0.13x means the balance sheet is essentially unlevered, making that ROIC genuinely impressive for an EMS company.
- CCS segment income grew 58.4% YoY on 41.6% revenue growth, implying margin expansion within the high-growth segment. CCS segment margin improved from ~7.4% in FY2024 to ~8.2% in FY2025, showing Celestica is capturing more value as AI infrastructure scales.
- Communications revenue surged 80.6% YoY to $7.1B, accelerating from 47.5% the prior year. This single sub-segment now represents over 57% of CCS revenue, up from roughly 41% in FY2024, reflecting hyperscaler AI networking demand concentration.
- SBC/revenue at just 0.56% is remarkably low for a tech-adjacent company. With buyback yield of 1.9%, share repurchases run at roughly 3.4x the dilution from stock comp, meaning shareholders are seeing genuine net share count reduction.
- Interest coverage at 23x with OCF-to-debt of 88% means Celestica could retire its entire $776M debt load in roughly 14 months from operating cash flow alone. The debt grade of 7.4/10 understates how clean this balance sheet actually is.
Risk Factors
- FCF conversion to net income is only 55%, and FCF-to-OCF is 69.5%, meaning capex is consuming a growing share of cash generation. With capex/depreciation at 1.15x and a negative FCF conversion trend, the company is investing more than it's replacing, pressuring free cash flow quality.
- P/FCF of 69x versus P/E of 38x is a wide gap, confirming that reported earnings significantly overstate cash generation. At a 1.45% FCF yield, investors are paying a steep price for cash flows that haven't kept pace with the earnings acceleration.
- Enterprise revenue declined 18.9% YoY in FY2025 after growing 29.4% the prior year, a 48-point swing. This segment is being cannibalized by Communications within CCS, raising concentration risk around hyperscaler networking spend.
- ATS segment revenue has essentially flatlined, growing just 1.5% YoY after declining 4.9% the prior year. At $3.2B, ATS is now only 26% of total revenue versus 37% two years ago. The diversification benefit from aerospace, defense, and industrial is eroding fast.
- Cash conversion cycle of 82.5 days is elevated for an EMS business. DSO of 69 days combined with DIO of 66 days against DPO of only 53 days means Celestica is financing significant working capital for its customers, tying up cash as revenue scales.
The semiconductor space in Canada basically comes down to one name, and that’s both the appeal and the risk. You’re making a concentrated bet on a single company’s ability to keep executing in a market that’s moving incredibly fast. There’s no diversification within the sector up here. You either believe in the business or you don’t.
What I keep coming back to is how rare it is to find a Canadian company with this kind of global relevance in a sector that actually matters for the next decade. That’s not something you can manufacture, and it’s not something the TSX gives you very often. But scarcity alone isn’t an investment thesis. The numbers have to back it up at the price you’re paying, and that’s where your own homework matters most.
